Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online February 15, 2011.
Article Versions
- Earlier version (February 8, 2011 - 05:14).
- You are viewing the most recent version of this article.
Copyright & Usage
U.S. Government work not protected by U.S. copyright
Author Information
- Bertil B. Fredholm,
- Adriaan P. IJzerman,
- Kenneth A. Jacobson,
- Joel Linden and
- Christa E. Müller
- Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (B.B.F.); Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, Leiden, the Netherlands (A.P.IJ.); Molecular Recognition Section, Laboratory of Bio-organic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland (K.A.J.); Division of Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, California (J.L.); and PharmaCenter Bonn, University of Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, Bonn, Germany (C.E.M.)
- Address correspondence to:
Bertil Fredholm, Karolinska Institutet, Nanna Svartz 2, Stockholm, Sweden, S-171 77. E-mail: bertil.fredholm{at}ki.se
Statistics from Altmetric.com
Article usage
In this issue
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
Jump to section
- Article
- Abstract
- I. Introduction
- II. Receptor Structure
- III. Receptor Oligomerization
- IV. Receptor Polymorphisms and Disease Susceptibility
- V. Genetically Modified Animals
- VI. Receptor Classification: New Drugs
- VII. Allosterism
- VIII. Drugs in the Clinic
- IX. Concluding Remarks
- Authorship Contributions
- Acknowledgments
- Footnotes
- References
- Figures & Data
- Info & Metrics
- eLetters